Emese Filka

Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

Albert Lai, Anh Tran, Phioanh L. Nghiemphu et al. · Journal of Clinical Oncology · 2010 · 451 citations · Full text

Phase II Pilot Study of Bevacizumab in Combination with Temozolomide and Regional Radiation Therapy for Up-Front Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Interim Analysis of Safety and Tolerability

Albert Lai, Emese Filka, B. McGibbon et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 184 citations

Neuro-oncology, Interim Analysis, Radiation Medicine +10

Two studies evaluating irinotecan treatment for recurrent malignant glioma using an every-3-week regimen

Timothy F. Cloughesy, Emese Filka, John G. Kuhn et al. · Cancer · 2003 · 117 citations

Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment

Xiao–Tang Kong, Nhung Nguyen, Yoon Ji Choi et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 57 citations · Full text

Neuro-oncology, Radiation Medicine, Radiation Therapy +10

Irinotecan Treatment for Recurrent Malignant Glioma Using an Every-3-Week Regimen

Timothy F. Cloughesy, Emese Filka, Gillian Nelson et al. · American Journal of Clinical Oncology · 2002 · 41 citations